Skip to content
MedsAcross

Medicine

Budesonide 3 mg capsule

Budesonide · Oral
Available on requestPrescription onlyUS FDAGeneric name

Budesonide 3 mg capsule is a generic prescription medicine for oral use, made by 8 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 25°C (77°F), excursions permitted to 15-30°C (59-86°F).

Key facts

Active ingredient (INN)
Budesonide
Brand
Sold under the generic name
Strength
3 mg
Dosage form
Capsule
Route
Oral
Packs
100 capsules, 500 capsules, 30 capsules and 17 more
Manufacturers
Zydus LifesciencesIndiaBryant Ranch PrepackAmerican Health PackagingGolden State Medical SupplyMajor PharmaceuticalsNorthStar RxPadagisRemedyrepack
Origin register
US FDA, United States
Storage
Store at 25°C (77°F), excursions permitted to 15-30°C (59-86°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
A07EA06 Budesonide
HS code (indicative)
3004.32Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
2 October 2001
Identifiers
RxCUI 1244214DailyMed set ID 33def4dc-b469-f987-e063-6294a90ace0b, 263303c2-8e4f-7b6c-e063-6394a90aef9e, 4a8e79df-3946-4e9a-b214-e9fdd824b565 +6NDC 72162-2473, 51407-591, 60687-596 +6Application NDA021324, ANDA206134

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
100 capsule, coated pellets in 1 bottle68382-720-01Zydus LifesciencesIndia8 June 2017
500 capsule, coated pellets in 1 bottle68382-720-05Zydus LifesciencesIndia8 June 2017
30 capsule, coated pellets in 1 bottle68382-720-06Zydus LifesciencesIndia8 June 2017
1000 capsule, coated pellets in 1 bottle68382-720-10Zydus LifesciencesIndia8 June 2017
90 capsule, coated pellets in 1 bottle68382-720-16Zydus LifesciencesIndia8 June 2017
10 blister pack in 1 carton / 10 capsule, coated pellets in 1 blister pack68382-720-77Zydus LifesciencesIndia8 June 2017
1000 capsule, coated pellets in 1 bottle70771-1075-0Zydus LifesciencesIndia8 June 2017
100 capsule, coated pellets in 1 bottle70771-1075-1Zydus LifesciencesIndia8 June 2017
30 capsule, coated pellets in 1 bottle70771-1075-3Zydus LifesciencesIndia8 June 2017
10 blister pack in 1 carton / 10 capsule, coated pellets in 1 blister pack70771-1075-4Zydus LifesciencesIndia8 June 2017
500 capsule, coated pellets in 1 bottle70771-1075-5Zydus LifesciencesIndia8 June 2017
90 capsule, coated pellets in 1 bottle70771-1075-9Zydus LifesciencesIndia8 June 2017
1 bottle in 1 carton / 100 capsule in 1 bottle0574-9855-10Padagis29 June 2018
20 blister pack in 1 box, unit-dose / 1 capsule, coated pellets in 1 blister pack60687-596-32American Health Packaging9 March 2021
1 bottle in 1 carton / 100 capsule in 1 bottle72162-2473-1Bryant Ranch Prepack24 April 2025
1 bottle in 1 carton / 100 capsule in 1 bottle72162-2473-2Bryant Ranch Prepack24 April 2025
100 capsule in 1 bottle51407-591-01Golden State Medical Supply24 October 2024
20 blister pack in 1 carton / 1 capsule, coated pellets in 1 blister pack0904-7313-10Major Pharmaceuticals3 September 2024
100 capsule, coated pellets in 1 bottle16714-829-01Northstar Rx25 June 2018
50 pouch in 1 box / 1 capsule, coated pellets in 1 pouch70518-4613-0Remedyrepack23 April 2026

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 14 February 1994Drugs@FDA
EU (EMA)AuthorisedEMA medicines data
India (CDSCO)Not yet confirmed against CDSCO approval lists—
AustriaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BelgiumRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BulgariaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CroatiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CyprusRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CzechiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
DenmarkRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
EstoniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FinlandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FranceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GermanyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GreeceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
HungaryRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IcelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IrelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
ItalyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LatviaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LiechtensteinRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LithuaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LuxembourgRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
MaltaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NetherlandsRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NorwayRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PolandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PortugalRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
RomaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SlovakiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SloveniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SpainRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SwedenRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Budesonide

Clinical summary

Budesonide is a corticosteroid indicated for maintenance treatment of asthma and as prophylactic therapy in children 12 months to 8 years of age, among other approved uses. MedsAcross supplies Budesonide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Budesonide

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Budesonide 3 mg capsule for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.